IMC-004(Immuno Cure)

N/A

Report date: 2023/08/03 09:37:06

Base Information

Drug NameIMC-004(Immuno Cure)
Drug Alias NameIMC-004
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionProgrammed cell death protein 1 blockers
TargetsProgrammed cell death protein 1
Therapy Area/IndicationsLiver NeoplasmsColorectal Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesImmuno Cure BioTech Ltd
China Registration ClassN/A

Develop Information

Active CompaniesImmuno Cure BioTech Ltd
Inactive CompaniesN/A
Active IndicationsLiver NeoplasmsColorectal Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A